After 50% tariff and H1B restrictions, Trump puts 100% duty on branded pharma: Indian stocks tumble
The U.S. President has imposed a 100% tariff on imported branded and patented drugs, effective October 1, unless companies establish manufacturing plants in America. The move rattled Indian pharmaceutical stocks and sent ripples across global markets. Here’s what it means for India’s $12 billion drug exports to the U.S., and why investors are worried.
READ MORE:
Other India Videos
Shivakumar launches SIR drive in Karnataka; urges voters to update records for welfare benefits
‘Defence production soars to record Rs 1.78 lakh crore’: Rajnath Singh at Vibrant Gujarat
Kashmir Police, CRPF, SDRF hold full-scale security mock drill ahead of Amarnath Yatra 2026
TMC Saugata Roy opposes proposed Bengal UCC: ‘Removing personal laws will hurt religious beliefs’
'US-India relationship at lowest point in 30 years': Congressman Ro Khanna slams Trump's policies
